Another topic of highest importance for our membership is health technology assessAnother topic of highest importance for our membership is health technology assessment. To best respond and advise on the developments of HTA in Europe from a political and strategic, as well as clinical and scientific, standpoint, COCIR has created a dedicated Health Technology Assessment Task Force.
COCIR continues to lead the way in the Medical Software arena for which the regulatory framework needs some clarification as there is a lack of harmonization on obligations in various Member States. COCIR continues to be very active on the international stage, as well as in Europe. As part of our chairmanship of the international association DITTA, we have a focused Task Force (amongst others) on medical software, bringing our high-level competence to the discussions with regulators. We will be present at IMDRF in San Francisco on 25-27 March.
Our China Desk continues to play a key role in supporting our members to shorten the time to market and to monitor regulatory developments in China. A number of new regulatory initiatives are expected from China in the coming months.
We are looking forward to a great year for all our members and the industries we represent.
Brussels, 23 January 2014